Evaluation of the anti-Thomsen –Friedenreich antibodies Nemod-TF1 and Nemod-TF2 as prognostic markers in breast cancer

ConclusionsThe data presented here further support a role of TF in BC tumor biology. Whether anti-TF directed treatment approaches may gain clinical relevance in those cases determined as triple negative or TA-MUC1 positive remains to be determined.
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research